Results 211 to 220 of about 24,348 (233)

Predicting progression of RA-ILD using anti-CCP

1.5 Diffuse Parenchymal Lung Disease, 2015
Background: ILD is a frequent extra-articular manifestation of Rheumatoid Arthritis (RA) contributing to significant morbidity and mortality. Factors that predict prognosis of ILD are unclear however high levels of anti-CCP have been reported to indicate disease progression in RA-ILD.
Paul Minnis, Karol Henry, Brigid Clark, Michael P. Keane   +3 more
openaire   +1 more source

The role of the shared epitope in arthralgia with anti-cyclic citrullinated peptide antibodies (anti-CCP), and its effect on anti-CCP levels

Annals of the Rheumatic Diseases, 2008
Patients presenting with both arthralgia and antibodies to cyclic citrullinated peptide (anti-CCP) have an increased risk of developing rheumatoid arthritis (RA). To further characterise this patient group and shed more light on its relationship with clinically manifest early arthritis and established RA, an immunogenetic and serological analysis was ...
Bos, W. H., Ursum, J., de Vries, N. [=Niek], Bartelds, G. M., Wolbink, G. J., Nurmohamed, M. T., van der Horst-Bruinsma, I. E., van de Stadt, R. J., Crusius, J. B. A., Tak, P. P., Dijkmans, B. A. C., van Schaardenburg, D.   +11 more
openaire   +4 more sources

Anti-CCP og reumatoid artrit

2007
Udgivelsesdato ...
Grinsted, Per, Junker, Peter, Lillevang, Søren Thue   +2 more
openaire   +1 more source

Clinical Utility of the Anti‐CCP Assay: Experiences with 700 Patients

Annals of the New York Academy of Sciences, 2005
Abstract: Our objective was to determine the frequency of antibodies to cyclic citrullinated peptides (CCPs) in a series of patients with a variety of rheumatic diseases. Seven hundred consecutive serum samples from patients at an outpatient clinic were tested for the presence of rheumatoid factor (RF) and anti‐CCP.
Ulrich, Sauerland, Heidemarie, Becker, Matthias, Seidel, Heiko, Schotte, Peter, Willeke, Annette, Schorat, Bernhard, Schlüter, Wolfram, Domschke, Markus, Gaubitz   +8 more
openaire   +2 more sources

BioPlex Anti-CCP Kits

Biomedical Safety & Standards, 2023
openaire   +1 more source

Rheumatoid Factor and Anti-CCP Titers in COVID-19

Infectious Disorders - Drug Targets
Introduction: The mechanisms of Coronavirus Disease 2019 (COVID-19) remain not fully elucidated. The present study aimed to trace the presence of autoantibodies among COVID-19 patients and to determine the association between COVID-19 and these antibodies.
Mudathir Abdelshafea Abdelkareem Abakar, Mohamed Ibrahim Awadab, Zohair Khalid Ibrahim Elaraki, Mohammed Elsheikh Osman, Mohamed Ahmed Ibrahim– Holi, Eltayib Hassan Ahmad-Abakur, Tarig M. S. Alnour   +6 more
openaire   +1 more source

Anti-CCP antibodies as a marker of rhupus

Lupus, 2015
J, Amaya-Amaya, N, Molano-González, J-S, Franco, M, Rodríguez-Jiménez, A, Rojas-Villarraga, J-M, Anaya   +5 more
openaire   +2 more sources

Valeur diagnostique des anti-CCP

Revue du Rhumatisme, 2006
S. Hassen - Zrour, N. Mokni, M. Touzi, I. Béjia, M. Younes, N. Bergaoui   +5 more
openaire   +1 more source

Arthralgien mit Nachweis von Anti-CCP-Antikörpern

Zeitschrift für Rheumatologie, 2021
openaire   +1 more source

RF vs. anti-CCP: competitor or companion?

Rheumatology International, 2010
Duck-An, Kim, Think-You, Kim
openaire   +2 more sources